Congress trades in Tekla Life Sciences Investors (HQL)
Financial Services · Asset Management
1 member of Congress has disclosed 2 trades in Tekla Life Sciences Investors (HQL) since 2020: 1 buy and 1 sale. The most recent was disclosed on Nov 3, 2022.
- Trades disclosed
- 2
- Members trading
- 1
- Buys / sells
- 1 / 1
- Reported value
- $2K–$30K
Who traded HQL
MemberBuysSalesLast disclosed
- Sen. Thomas R. Carper (D-DE)1 buy · 1 sale11Nov 3, 2022
All trades
DisclosedTradeAmount
- Nov 3, 2022$1K–$15K
Sen. Thomas R. Carper (D-DE)
Sold (full) Tekla Life Sciences Investors HQL
$1K–$15K · Traded Oct 4, 2022 · disclosed Nov 3, 2022 · Spouse
- Mar 3, 2020$1K–$15K
Sen. Thomas R. Carper (D-DE)
Bought Tekla Life Sciences Investors HQL
$1K–$15K · Traded Feb 22, 2020 · disclosed Mar 3, 2020 · Spouse
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.